History

Our History – Step by Step

1990
1990

Poland is entering a new stage in its history. The end of communism, the transition to a free-market economy, and the advent of democracy have ushered in a new era for the healthcare sector. At the same time, new challenges have emerged regarding access to medicines and the establishment of a secure supply chain for delivering them to pharmacies and hospitals. In response to these challenges, the pharmaceutical wholesaler "Medicines" was founded in Łódź by Jacek Szwajcowski and Zbigniew Molenda.

1998
1998

Medicines S.A. became the first company in the pharmaceutical distribution industry to go public on the Warsaw Stock Exchange. That same year, the company changed its name to Polska Grupa Farmaceutyczna S.A. and began a series of mergers, becoming a nationwide company.

1999
1999

The company merges with Urtica Zaopatrzenie Farmaceutyczne Szpitali Sp. z o. o. (now Urtica Sp. z o. o.), marking the start of its hospital wholesale operations. Today, Urtica is Poland’s largest distributor of medications for inpatient care. One out of every three medications delivered to hospitals in Poland comes from Urtica’s warehouses.

2001
2001

The company began its operations in the retail sector. Today, DOZ S.A. is a leader in the Polish pharmacy market. The company works with over 1,300 "DOZ Apteki dbam o zdrowie" (DOZ Pharmacies – Caring for Health) locations, making it the largest employer of pharmacists in Poland. DOZ S.A. and its subsidiaries employ 7,000 people who, guided by the mission "The Patient at the Center of Attention," ensure the safety of pharmacological treatment for 7 million patients every month. The company also develops a portfolio of its own brands, the high quality of which is valued by patients.

2007
2007

A subsidiary, UAB Nacionaline Farmacijos Grupe, is being established to acquire majority stakes in several Lithuanian companies. These include Limedika (one of the largest pharmaceutical wholesalers in Lithuania), as well as Gintarine vaistine and Norfos vaistine, which operate pharmacies. We are currently the leader in the Lithuanian healthcare market.

In the same year, the company established the DOZ "Dbam o Zdrowie" (I Care About Health) Foundation, with the goal of removing barriers to accessing medication. Guided by the mission "Helping people enjoy life," the DOZ Foundation currently focuses its efforts on seniors, supporting them in maintaining a high quality of life and preventing social exclusion.

2008
2008

CEPD N.V. was established to develop a retail pharmacy network across Europe. Today, it is one of the leading European pharmaceutical groups, with a presence in 11 markets. It works with over 1,800 pharmacies in Poland, Lithuania, and Sweden, which together form the third-largest pharmacy chain in the European Union. The company offers a wide range of pharmaceutical services, available both through brick-and-mortar pharmacies and online.

In the same year, the company launched the website www.doz.pl, which is now the leader in healthcare e-commerce in Poland and one of the most recognizable brands on the internet. Currently, the site attracts over 8 million unique users per month, with new orders being placed every two seconds—ready for patients to pick up in the shortest possible time. However, DOZ.pl offers much more: access to pharmacists who educate patients, provide advice, and ensure that the medications ordered do not interact with one another.

Also in 2008, in recognition of the centuries-old tradition of Polish pharmacy, the company opened the Prof. Jan Muszyński Museum of Pharmacy at Plac Wolności 2 in Łódź, and assumed the role of its patron.

2009
2009

Pharmalink has been established to provide specialized, comprehensive logistics services for the pharmaceutical industry. The company delivers medications to retail pharmacies, hospital pharmacies, wholesalers, medical clinics, private medical practices, and even individual patients. Pharmalink operates throughout Poland and also extends its services internationally, organizing cross-border transport—primarily within the European Union.

2011
2011

The company’s organizational model is changing. Operational activities within the business lines are being transferred to subsidiaries, which are independently responsible for building their own value and brand. The newly established holding company, Pelion S.A., exercises ownership oversight over all areas of the company’s operations.

In the same year, the company organized the first DOZ Marathon Łódź—a running event aimed at promoting health, a healthy lifestyle, and physical activity, as well as popularizing a modern model of charity that combines running with helping those in need.

2017
2017

After 20 years on the Warsaw Stock Exchange, our company is concluding its journey in the capital market. Pelion entered the exchange as a local pharmaceutical wholesaler and is leaving it as the largest Polish company in the healthcare sector.

In the same year, the Urtica Dzieciom Foundation is established, with a mission to provide art therapy and psycho-oncological support so that children battling cancer can recover more quickly and smoothly. The goal of Urtica Dzieciom’s flagship project — run since 1997 — is to support young patients of oncology and haematology wards in Poland.

2020
2020

In response to the challenges posed by the pandemic, we established the Dimedic clinic, where doctors provide consultations for patients regarding potential coronavirus infections. Through this initiative, we support and help alleviate the burden on Poland’s healthcare system. As coronavirus vaccines arrived on the Polish market, Pelion became a key link in the largest-scale logistics operation dedicated to the health of the Polish people.

2021
2021

CEPD N.V. has become the owner of the Lloyds Apotek (now DOZ Apotek) pharmacy chain in Sweden. The company is introducing a pioneering patient care solution there: in partnership with Wolt, it offers home delivery of prescription medications—reaching the patient in as little as 30 minutes following a teleconsultation and the issuance of a prescription.

2022
2022

We are launching a strategic investment in the healthcare sector in Poland. In Łódź, on Kinga C. Gillette Street, the largest pharmaceutical warehouse in Poland—and one of the largest in Central Europe—is opening. From here, medications are delivered to thousands of pharmacies and several hundred hospitals throughout Poland.

In the same year, in response to the greatest humanitarian crisis in decades—triggered by the war in Ukraine—we launched Health4Ukraine, the largest targeted healthcare aid initiative in Europe for forced migrants from Ukraine. Nearly 300,000 women, children, and elderly people who sought refuge in Poland received assistance with the purchase of medicines, totaling nearly 71 million PLN. This globally unique program, initiated by the company epruf S.A., provided support to one in every five refugees from Ukraine in Poland.

2025
2025

Our company is becoming an investor in DocMorris AG, a leading player in the online pharmacy, marketplace, and professional healthcare sectors, with operations in countries including Switzerland, Germany, Spain, Portugal, and France.

That same year, Pharmalink opened a new 24,000-square-meter logistics center on Świętej Teresy od Dzieciątka Jezus Street in Łódź. The project was designed with sustainability in mind. The BREEAM Excellent certification confirms that the building meets the requirements of the most stringent environmental standards—from efficient energy management and reduced emissions to minimizing waste generation. This is the first phase of a project that sets the course for the company’s development in the coming years.

The year 2025 also marks the company’s 35th anniversary. The history of Pelion is a story of innovation in healthcare and the implementation of modern—often pioneering—solutions for patients and clients. It also serves as an example of how Poland’s free-market economy emerged and grew in strength. Having begun its operations on December 20, 1990, by supplying medicines to a few pharmacies, the company now employs over 11,000 people across several European countries. It manages the largest pharmacy chain in Poland and Lithuania—which is also the third-largest in the European Union—leads the market in supplying medicines to hospitals in Poland, and holds the top position in the field of pharmaceutical insurance services. More than 350 million Europeans have access to the products and services offered by Pelion’s companies.

2026
2026

Atida, an international online pharmacy with a presence in Spain, France, Italy, Germany, the Netherlands, Austria, Portugal, and Belgium, is joining CEPD N.V.—a leading company in the European pharmacy market, which operates in Poland, Lithuania, and Sweden. Following this merger, the combined entity offers an extensive and complementary range of pharmacy services, provided both online and through brick-and-mortar locations. The merger brings together CEPD N.V.’s deep pharmaceutical expertise and experience in patient care—across both physical and digital pharmacy channels—with Atida’s robust digital platform and its diverse portfolio of health brands, which are present in markets throughout Europe.